Pankaj Kedia knows how to please the Gods with his guitar strums
For the MD-emerging markets of Dolby Laboratories, getting back to a childhood hobby has opened doors to spirituality
Shailaja Mohapatra - January 15, 2021
Why EMs are more immune to COVID-19 disruption than DMs
GMO’s EM equity team makes a case for MSCI EM Index’s resilience and speedy recovery
July 30, 2020
"In India, valuations appear stretched and growth projections unrealistic"
Ben Inker, head of GMO’s Asset Allocation team, explains why emerging markets figure highly in their portfolio, but India and the US not as much
Rajesh Padmashali - May 31, 2019
Uneasy Calm
Flush with cash, institutional investors are paying a high price for a cheery consensus. Those lining up for a fire sale may not have to wait too long
Rajesh Padmashali - May 29, 2019
Keeping it in the family
The focus on long-term return is making family-controlled enterprises more powerful in emerging markets
Glen Finegan - November 27, 2018
Credit Where It Is Due
Some companies are going beyond their brief and creating conditions for women employees to succeed
N Mahalakshmi - September 12, 2018
Emerging Markets—No Reward Without Risk
While there may be more pain in the short term, emerging markets are still the best investment opportunity available today
Ben Inker - August 22, 2018
Packing a punch
After emerging as the global leader in the oral care segment, Essel Propack is betting on the non-oral space to sustain its growth momentum
Jash Kriplani - March 20, 2018
Career Risk and Stalin’s Pension Fund
The GMO co-founder on why fund managers could perforce end up investing in emerging markets
Jeremy Grantham - December 15, 2017
"To make this market exuberant enough for a bust will take considerably higher prices"
GMO’s co-founder and stoic polymath, Jeremy Grantham strongly believes in emerging markets
N Mahalakshmi - August 22, 2017
